Ozempic Is Moving a Bunch of Stocks Wednesday Morning
Stock markets looked poised to continue their winning ways on Wednesday morning, as Stock index futures were higher across the board. Investors will get a look today at the latest thought process from the Federal Reserve when it releases the minutes of its most recent monetary policy committee meeting. They're hopeful that what they read will support the case for leaving interest rates alone when the central bank gathers for its next meeting.
A host of stocks in the healthcare sector made some big moves early Wednesday. News on the popular Ozempic treatment helped push shares of some companies higher, including Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY). However, not every company was as fortunate, as shareholders in DaVita (NYSE: DVA) and Fresenius Medical Care (NYSE: FMS) can attest. Here's what you need to know about Ozempic right now and why these companies' shares are reacting the way they are.
On the winning side, the pair of drug developers got a nice boost. Novo Nordisk shares were up almost 4% in premarket trading, while Eli Lilly added early 3% early Wednesday morning.
Source Fool.com
